Peritoneal surface malignancies comprise a heterogeneous group of primary tumours,
including peritoneal mesothelioma, and peritoneal metastases of other tumours, including …

Peritoneal metastasis (PM) is often regarded as a less frequent pattern of spread; however,
collectively across all spectra of primary tumors, the consequences of PM impact a large …

Metastatic peritoneal carcinoma (mPC) is a deadly disease without effective treatment. To
improve treatment of this disease, a recently developed hyperthermic intraperitoneal …

Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Background Enhanced recovery after surgery (ERAS) pathways have been shown to
considerably reduce complications, length of stay and costs after most of surgical …

Objectives The therapeutic efficacy of cytoreductive surgery (CRS) plus hyperthermic
intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis (PC) from …

Background: Adequate selection of patients with peritoneal metastasis (PM) for
cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) …

Metastatic disease occurs in half of people with colorectal cancer (CRC). Metastasis spread
through hematogenous or lymphangitic routes and may occur in lymph nodes, liver, lung …

Objective To review our 25‐year experience with hyperthermic intra‐peritoneal
chemotherapy (HIPEC). Background Combining cytoreductive surgery (CRS) and HIPEC as …

Importance The peritoneal surface is a common site of disease in ovarian and colorectal
cancer. Peritoneal metastases carry a poor prognosis, despite maximal therapeutic efforts …